Mifepristone vs Misoprostol
ConditionCervical Preparation
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorMontefiore Medical Center
About this trial
The Investigator team hypothesizes that in a randomized trial comparing mifepristone-alone or misoprostol-alone for cervical preparation for procedural abortions at 12 to 16 weeks in hospital-based care, the proportion of patients who achieve successful cervical dilation will be different between the study groups.
Eligibility criteria
Qualifiers
English or Spanish-speaking
Capacity to consent
Seeking induced abortion of a singleton pregnancy between 12 weeks, 0 days and 16 weeks, 6 days (based on age at day of surgery)
Disqualifiers
History of more than two prior Cesarean deliveries
Sonographic evidence of placenta previa
Sonographic concern for morbidly adherent placenta
Prior obstetric hemorrhage requiring transfusion
Trial design
Treatments tested in this trial
- Mifepristone
- Misoprostol
Treatment groups
94 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov